MX9202015A - Esteres aril alquilicos de acido 4,5-di hidroxi -9,10- di hidro-9,10-di oxo --2- antracen carboxilico que tienen actividad terapeutica. - Google Patents

Esteres aril alquilicos de acido 4,5-di hidroxi -9,10- di hidro-9,10-di oxo --2- antracen carboxilico que tienen actividad terapeutica.

Info

Publication number
MX9202015A
MX9202015A MX9202015A MX9202015A MX9202015A MX 9202015 A MX9202015 A MX 9202015A MX 9202015 A MX9202015 A MX 9202015A MX 9202015 A MX9202015 A MX 9202015A MX 9202015 A MX9202015 A MX 9202015A
Authority
MX
Mexico
Prior art keywords
antracen
carboxyll
hydro
oxo
hydroxy
Prior art date
Application number
MX9202015A
Other languages
English (en)
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Publication of MX9202015A publication Critical patent/MX9202015A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/95—Esters of quinone carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
MX9202015A 1991-05-03 1992-04-30 Esteres aril alquilicos de acido 4,5-di hidroxi -9,10- di hidro-9,10-di oxo --2- antracen carboxilico que tienen actividad terapeutica. MX9202015A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911215A IT1247884B (it) 1991-05-03 1991-05-03 Esteri arilalchilici dell'acido 4,5 diidrossi-9,10-diidro-9,10-diosso 2-antracencarbossilico ad azione terapeutica

Publications (1)

Publication Number Publication Date
MX9202015A true MX9202015A (es) 1992-11-01

Family

ID=11359835

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202015A MX9202015A (es) 1991-05-03 1992-04-30 Esteres aril alquilicos de acido 4,5-di hidroxi -9,10- di hidro-9,10-di oxo --2- antracen carboxilico que tienen actividad terapeutica.

Country Status (21)

Country Link
US (1) US5330981A (es)
EP (1) EP0537313B1 (es)
JP (1) JPH0692348B2 (es)
KR (1) KR100226082B1 (es)
AT (1) ATE133157T1 (es)
AU (1) AU648894B2 (es)
BR (1) BR9205255A (es)
CZ (1) CZ280027B6 (es)
DE (1) DE69207698T2 (es)
DK (1) DK0537313T3 (es)
ES (1) ES2082468T3 (es)
FI (1) FI104166B (es)
GR (1) GR3019417T3 (es)
HU (1) HUT63605A (es)
IT (1) IT1247884B (es)
MX (1) MX9202015A (es)
NO (1) NO179245C (es)
PT (1) PT100439B (es)
RU (1) RU2087462C1 (es)
SK (1) SK280738B6 (es)
WO (1) WO1992019584A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
AU2001285311B2 (en) 2000-08-29 2005-09-15 Biocon, Ltd Immunoregulatory compounds, derivatives thereof and their use
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
CN101475484B (zh) * 2009-01-05 2012-07-18 东南大学 骨靶向抗炎药物合成方法及其应用
CN103709052B (zh) * 2014-01-12 2016-01-27 何黎琴 一种大黄酸胺基醇酯类化合物、其制备方法及医药用途
CN104945269A (zh) * 2015-06-23 2015-09-30 常州善美药物研究开发中心有限公司 一种大黄酸羧酸酯类衍生物及其应用
CN109053798B (zh) * 2018-07-23 2020-11-17 遵义医科大学 一种大黄酸酯衍生物及其制备方法与应用
CN115521320B (zh) * 2021-06-25 2023-09-05 沈阳兴齐眼药股份有限公司 一种制备普拉洛芬的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis

Also Published As

Publication number Publication date
DE69207698D1 (de) 1996-02-29
GR3019417T3 (en) 1996-06-30
SK280738B6 (sk) 2000-07-11
FI925944A (fi) 1992-12-30
ES2082468T3 (es) 1996-03-16
DK0537313T3 (da) 1996-06-03
US5330981A (en) 1994-07-19
FI925944A0 (fi) 1992-12-30
NO179245C (no) 1996-09-04
PT100439A (pt) 1993-08-31
NO925048L (no) 1992-12-30
PT100439B (pt) 1999-10-29
KR100226082B1 (en) 1999-10-15
NO179245B (no) 1996-05-28
ATE133157T1 (de) 1996-02-15
AU1670092A (en) 1992-12-21
ITMI911215A0 (it) 1991-05-03
FI104166B1 (fi) 1999-11-30
FI104166B (fi) 1999-11-30
CZ386492A3 (en) 1993-06-16
WO1992019584A1 (en) 1992-11-12
NO925048D0 (no) 1992-12-30
HU9204171D0 (en) 1993-04-28
JPH0692348B2 (ja) 1994-11-16
SK386492A3 (en) 1995-04-12
CZ280027B6 (cs) 1995-09-13
RU2087462C1 (ru) 1997-08-20
HUT63605A (en) 1993-09-28
ITMI911215A1 (it) 1992-11-03
BR9205255A (pt) 1993-08-31
AU648894B2 (en) 1994-05-05
JPH05507733A (ja) 1993-11-04
EP0537313B1 (en) 1996-01-17
IT1247884B (it) 1995-01-05
EP0537313A1 (en) 1993-04-21
DE69207698T2 (de) 1996-07-18

Similar Documents

Publication Publication Date Title
ATE198830T1 (de) Verwendung von nikotinanalogen zur behandlung von degenerativen erkrankungen des nervensystems
PL298195A1 (en) Sulfonamido- and sulfonabidocabonyl-pyridine-2-carboxylic acid amides and their pyridine-n-oxides, method of obtaining them and their application as therapeutic agents as well therapeutic agents containing them and method of obtaining such therapeutic
DE69221501D1 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
LTIP919A (en) Drugs and process for preparing thereof
ATE38036T1 (de) Benzothiophenderivate als bronchodilatoren.
DE69614375D1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
PL310145A1 (en) Substituted derivatives of 4-phenyl 6-amino nicotinic acid, method of obtaining them and therapeutic agents containing such derivatives
MX9202015A (es) Esteres aril alquilicos de acido 4,5-di hidroxi -9,10- di hidro-9,10-di oxo --2- antracen carboxilico que tienen actividad terapeutica.
FR2478079B1 (fr) Lactate de calcium et d'ammonium et procede d'alimentation des animaux l'utilisant
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
KR890701099A (ko) 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질
DK0561846T3 (da) 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracencarboxylsyre-dicarbonater og -urethaner med terapeutisk virkning
DK0545983T3 (da) Mellemprodukter for chelateringsmidler med forud fastsat symmetri samt fremgangsmåde til fremstilling heraf
AU2659088A (en) Method for the treatment of anxiety
HUT61199A (en) Process for producing pharmaceutical compositions suitable for treating hyperlipidaemia and/or atherosclerosis
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
HUT64853A (en) Method for producing huminic acid and metal compounds as well as for application of said compounds as absorbent, antidoum or source of trace elements
DE69526519D1 (de) Silylierungsprocess
ES2019981B3 (es) Amido acido benzofurancarbono basico sustituido, metodo de fabricacion y productos terapeuticos contenidos
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
FR2684102B1 (fr) Procede de preparation de polyazidoalcools ainsi que de polyaminoalcools et polyazidothiols derives de ceux-ci.
GB2262886B (en) N-channel calcium antagonists useful for treating bronchial diseases
DE59609482D1 (de) Anellierte beta-carboline

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees